COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management

Autor: Carlo Alviggi, Sandro C. Esteves, Raoul Orvieto, Alessandro Conforti, Antonio La Marca, Robert Fischer, Claus Y. Andersen, Klaus Bühler, Sesh K. Sunkara, Nikolaos P. Polyzos, Ida Strina, Luigi Carbone, Fabiola C. Bento, Daniela Galliano, Hakan Yarali, Lan N. Vuong, Michael Grynberg, Panagiotis Drakopoulos, Pedro Xavier, Joaquin Llacer, Fernando Neuspiller, Marcos Horton, Matheus Roque, Evangelos Papanikolaou, Manish Banker, Michael H. Dahan, Shu Foong, Herman Tournaye, Christophe Blockeel, Alberto Vaiarelli, Peter Humaidan, Filippo M. Ubaldi, on behalf of the POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group

Publikováno v: Reproductive Biology and Endocrinology, Vol 18, Iss 1, Pp 1-7 (2020)

Abstract The prolonged lockdown of health services providing high-complexity fertility treatments –as currently recommended by many reproductive medicine entities– is detrimental for society as a whole, and infertility patients in particular. Glo

Externí odkaz: https://doaj.org/article/4f61f1c36c9a49e796e6610ad369cbc7

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists

Autor: Sandro C. Esteves, Carlo Alviggi, Peter Humaidan, Robert Fischer, Claus Y. Andersen, Alessandro Conforti, Klaus Bühler, Sesh K. Sunkara, Nikolaos P. Polyzos, Daniela Galliano, Michael Grynberg, Hakan Yarali, Irem Y. Özbek, Matheus Roque, Lan N. Vuong, Manish Banker, Laura Rienzi, Alberto Vaiarelli, Danilo Cimadomo, Filippo M. Ubaldi

Publikováno v: Frontiers in Endocrinology, Vol 10 (2019)

This article represents a viewpoint on the POSEIDON criteria by a group of clinicians and embryologists. Its primary objective is to contextualize the Poseidon criteria and their metric of success for the relevant Frontiers Research Topic “POSEIDON

Externí odkaz: https://doaj.org/article/0d58f41d39ab42e594682ed738a7772f

How should the best human embryo in vitro be? Current and future challenges for embryo selection

Autor: Danilo, Cimadomo, Federica, Innocenti, Marilena, Taggi, Gaia, Saturno, Maria, R Campitiello, Guido, Maurizio, Alberto, Vaiarelli, Filippo, M Ubaldi, Laura, Rienzi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3983::5195ff840e30c6b6a56c68a242faeac6
https://hdl.handle.net/11697/208759

Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trial

Autor: Andrea Lenzi, Herbert Valensise, Filippo M Ubaldi, R.L. Scala, Irene Martini, Carla Ferreri, Francesca Caruso, Enea Gino Di Domenico

Publikováno v: Trials 15 (2014). doi:10.1186/1745-6215-15-164
info:cnr-pdr/source/autori:Martini, Irene; Di Domenico, Enea Gino; Scala, Roberta; Caruso, Francesca; Ferreri, Carla; Ubaldi, Filippo M.; Lenzi, Andrea; Valensise, Herbert/titolo:Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trial/doi:10.1186%2F1745-6215-15-164/rivista:Trials/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume:15
Trials

Background Umbilical cord blood (UCB) is an important source of hematopoietic stem cells (HSCs). However, the concentration of cells in cord blood units is limited and this may represent the main restriction to their therapeutic clinical use. The per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72b41e8082298aed815927dae61afe7
https://doi.org/10.1186/1745-6215-15-164